Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 24 of 24 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company 3i-Nano | Activity: Research and Development | Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. Potential applications include cardiac, sepsis, meningitis, and respiratory. | Location Greensboro |
| |
Company Aceragen Inc. | Activity: Research and Development | Company Description Aceragen is a clinical-stage biopharmaceutical company developing therapeutics for rare and orphan pulmonary and rheumatic diseases with high unmet medical need. | Location Research Triangle Park |
| |
Company Adroit Pharmaceutical Development LLC | Activity: Contract Research and Testing | Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. | Location Durham |
| |
Company Aer Therapeutics | Activity: Research and Development | Company Description Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs. | Location Raleigh |
| |
Company Allergy Partners Extract Laboratory | Activity: Production and Manufacturing | Company Description Allergy Partners' Extract Laboratory produces extracts that are used to treat allergic disease, asthma and immunology. | Location Asheville |
| |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Cary |
| |
Company Arcus-Med LLC | Activity: Research and Development | Company Description Arcus-Med is developing software to diagnose pulmonary hypertension (PH). | Location Raleigh |
| |
Company Areteia Therapeutics Inc. | Activity: Research and Development | Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. | Location Chapel Hill |
| |
Company BioMarck Pharmaceuticals Ltd. | Activity: Research and Development | Company Description BioMarck develops drugs to treat pulmonary diseases and disorders, such as chronic obstructive pulmonary disease, ARDS, cystic fibrosis and lung cancer. | Location Durham |
| |
Company BioMedInnovations LLC | Activity: Research and Development | Company Description BioMedInnovations (BMI) develops products for ex vivo perfusion and preservation of organs and tissue. | Location Denver |
| |
Company Columbia Life Systems Inc. | Activity: Research and Development | Company Description Columbia Life Systems is developing a computer-controlled oxygen blender for therapeutic research. | Location Raleigh |
| |
Company Concentrx Pharmaceuticals Inc. | Activity: Research and Development | Company Description Concentrx develops inhaled prescription products for asthma and COPD, including a unit dose disposable dry powder inhaler. | Location Durham |
| |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham |
| |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville |
| |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill |
| |
Company North Carolina Clinical Research | Activity: Contract Research and Testing | Company Description North Carolina Clinical Research conducts phase one through four trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine and bioequivalent studies. | Location Raleigh |
| |
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham |
| |
Company Pneumocyte LLC | Activity: Research and Development | Company Description Pneumocyte develops technologies to diagnose and manage lung injuries. | Location Winston-Salem |
| |
Company Polarean Inc. | Activity: Production and Manufacturing | Company Description Polarean designs and manufactures equipment for production of hyperpolarized xenon or helium gas for use in MRI. Investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression and therapeutic response. | Location Durham |
| |
Company PulmonIx LLC | Activity: Contract Research and Testing | Company Description PulmonIx conducts pulmonary, asthma and critical care medicine clinical trials. PulmonIx @ LeBauer Cone Health is a national care center of the Pulmonary Fibrosis Foundation. | Location Greensboro |
| |
Company Renovion Inc. | Activity: Research and Development | Company Description Renovion is developing therapies for chronic inflammatory lung diseases including lung transplant, cystic fibrosis (CF), bronchiectasis and COPD. | Location Chapel Hill |
| |
Company Spirovation Inc. | Activity: Contract Research and Testing | Company Description Spirovation is a specialty CRO with a focus on the development of breakthrough drugs in respiratory medicine. Spirovation is non-profit, UNC-affiliated entity. | Location Chapel Hill |
| |
Company Sunday Therapeutics Inc. | Activity: Research and Development | Company Description Sunday Therapeutics is developing a humanized monoclonal antibody to prevent chronic lung disease. | Location Durham |
| |
Company Vast Therapeutics | Activity: Research and Development | Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. | Location Durham |